In FAP-negative 4T1 and Panc02 allografted models, infused FAP-CAR T cells can only recognize and therefore lyse tumor stromal fibroblasts to slow the tumor progression, proving deletion of CAFs a valuable tumor therapeutic approach. Here, FAP is linked to neoplasm.